已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Synthesis of Rovafovir Etalafenamide (Part I): Active Pharmaceutical Ingredient Process Development, Scale-Up, and Impurity Control Strategy

工艺工程 活性成分 过程(计算) 杂质 材料科学 过程开发 化学 放大 化学工程 比例(比率) 医药制造业 机组运行 生化工程 色谱法
作者
Eric A. Standley,Dustin A. Bringley,Selçuk Çalimsiz,Jeffrey D. Ng,Keshab Sarma,Jinyu Shen,David A. Siler,Andrea Ambrosi,Wen‐Tau T. Chang,Anna Chiu,Jason A. Davy,Ian J. Doxsee,Mihaela M. Esanu,Jeffrey A. O. Garber,Youri Kim,Bernard Kwong,Olga B. Lapina,Edmund Leung,Lennie Lin,Andrew Martins,Jenny Phoenix,Jaspal Phull,Benjamin Roberts,Bing‐Feng Shi,Olivier St‐Jean,Xiang Wang,Li Wang,Nande Wright,Guojun Yu
出处
期刊:Organic Process Research & Development [American Chemical Society]
卷期号:25 (5): 1215-1236 被引量:6
标识
DOI:10.1021/acs.oprd.1c00059
摘要

This manuscript describes the chemical process development and multi-kilogram synthesis of rovafovir etalafenamide (GS-9131), a phosphonamidate prodrug nucleotide reverse transcriptase inhibitor under investigation for the treatment of HIV-1 infection. Rovafovir etalafenamide is assembled in a four-step sequence beginning from the nucleoside core and an elaborated phosphonamidate alcohol. The assembly starts with a decarboxylative elimination of a β-hydroxyacid to yield the corresponding cyclic enol ether, which is subsequently coupled to a functionalized phosphonamidate alcohol in an iodoetherification reaction. Oxidative syn elimination then installs the required fluoroalkene, after which a final deprotection reaction yields the active pharmaceutical ingredient (API). Understanding the genesis, fate, and purge of the des-fluoro analog of the API, a mitochondrial toxin, proved to be a central driver in the development of the manufacturing route and impurity control strategy. Initial control strategies revolved around the use of silica gel chromatography or simulated moving bed chromatography to purge the des-fluoro impurity to an acceptable level, but ultimately a chromatography-free approach to mitigate the formation of this impurity was devised that expanded manufacturing flexibility. Design of experiments was used to improve the iodoetherification fragment coupling reaction and to reduce the level of the des-fluoro impurity formed in this step. Furthermore, several new crystalline intermediate forms were discovered and implemented as isolation points to bolster the overall impurity control strategy for standard, diastereomeric, and potentially mutagenic impurities as well as for the des-fluoro impurity. These processes were executed on multi-kilogram scale to produce API for clinical studies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
qianchimo完成签到 ,获得积分10
2秒前
xiemeili完成签到 ,获得积分10
3秒前
Osiris完成签到,获得积分10
4秒前
5秒前
6秒前
Diligency完成签到 ,获得积分10
6秒前
11秒前
飞翔的霸天哥应助emm采纳,获得30
11秒前
houfei发布了新的文献求助10
12秒前
15秒前
16秒前
chenyuns发布了新的文献求助20
16秒前
冰西瓜完成签到 ,获得积分10
23秒前
尘尘完成签到,获得积分10
26秒前
似水流年完成签到 ,获得积分10
27秒前
jhlz5879完成签到 ,获得积分10
27秒前
Jessie发布了新的文献求助30
28秒前
chenyuns发布了新的文献求助10
34秒前
krajicek完成签到,获得积分10
36秒前
棉袄完成签到 ,获得积分10
36秒前
aiiLuX完成签到 ,获得积分10
45秒前
晨云完成签到,获得积分10
45秒前
Dobby发布了新的文献求助10
48秒前
撒撒188完成签到,获得积分20
48秒前
李健飞完成签到 ,获得积分10
52秒前
称心的语梦完成签到,获得积分10
52秒前
52秒前
撒撒188发布了新的文献求助10
53秒前
九天发布了新的文献求助10
54秒前
昌莆完成签到,获得积分10
56秒前
Cupid完成签到,获得积分10
57秒前
57秒前
852应助Dobby采纳,获得10
58秒前
张佳明完成签到 ,获得积分10
58秒前
1分钟前
ZJ完成签到,获得积分10
1分钟前
毛123完成签到,获得积分10
1分钟前
魔幻的访冬完成签到,获得积分10
1分钟前
1分钟前
chenyuns发布了新的文献求助10
1分钟前
高分求助中
The ACS Guide to Scholarly Communication 2500
Sustainability in Tides Chemistry 2000
Pharmacogenomics: Applications to Patient Care, Third Edition 1000
Studien zur Ideengeschichte der Gesetzgebung 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Threaded Harmony: A Sustainable Approach to Fashion 810
《粉体与多孔固体材料的吸附原理、方法及应用》(需要中文翻译版,化学工业出版社,陈建,周力,王奋英等译) 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3085205
求助须知:如何正确求助?哪些是违规求助? 2738111
关于积分的说明 7548402
捐赠科研通 2387728
什么是DOI,文献DOI怎么找? 1266084
科研通“疑难数据库(出版商)”最低求助积分说明 613281
版权声明 598492